LabConnect Reveals SciOps Support Team

Tuesday, October 30, 2012 09:53 AM
Seattle-based LabConnect has launched a new service, Scientific Operations Support (SciOps), to offer unique functional outsourcing services to the pharmaceutical research industry.
 
According to president and CEO Eric Hayashi, LabConnect developed SciOps after executives perceived a need from clients for a team that could manage intricate clinical protocols as well as internal and external research development programs.
 
“We knew that we needed to go beyond the traditional outsourcing services,” Hayashi said. “With SciOps, clients get exactly who they need from our contract personnel to take on specific projects and research functions.”
 
LabConnect’s SciOps team gives its clients management control from the beginning, without the time and cost strains of managing internal headcount, payroll and human resources issues. Unlike other outsourcing services, clients have access to tap into the expertise of the company’s senior personnel or specialists within the team to improve study quality and process flow.
 
In addition to routine testing, sample tracking, data management and specialized testing, LabConnect’s professional support at all levels provides clients the ability to select the services that best fit their needs and budget.
 
“The degree of integration with client operation often allows the SciOps team to make specific, objective recommendations for product and process improvement,” Hayashi said.
 
LabConnect’s SciOps team members each have a minimum of 10 years’ experience.
 
Privately held LabConnect provides global central laboratory testing services to the biopharmaceutical industry to support drug development programs around the world. Its capabilities include routine and specialized testing, safety, esoteric, bioanalytical, pathology and biostorage and logistics services.
Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

February 25

Analysts: With market anticipation of Quintiles IPO, other CROs could soon file to go public

National Clinical Trial Network aims to link sponsors, minority patients for trials and access to new therapies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Sites rate the best
sponsors of 2013

Largest survey response ever puts Biogen Idec, Forest Labs, Bayer at top

As CRO industry
turns 30, a look back
at modest beginnings

Phenomenal growth, strategic partnering highlight evolution
of CROs

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Sized out of big deals,
mid-tier CROs still thriving

Finding market niches, strategies to stay vital in changing research enterprise

Industry leaders embrace disruptive innovations
Despite resistance to change, many exploring data sharing, open-source collaboration

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs